Moxalactam therapy for a wide spectrum of bacterial infections in adults. - Wikidata - awgldk - TriplyDB

Moxalactam therapy for a wide spectrum of bacterial infections in adults.

Moxalactam therapy for a wide spectrum of bacterial infections in adults.

http://www.wikidata.org/entity/Q35669539

about

A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy.Clinical experience with Moxalactam in the treatment of pseudomonal and nonpseudomonal infections.In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.Clinical and pharmacokinetic evaluation of parenteral moxalactam in infants and children.Ceftriaxone: in vitro studies and clinical evaluation Ceftriaxone (Ro 13-9904) therapy of serious infection.Comparison of moxalactam and gentamicin in the treatment of complicated urinary tract infections.Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections.Clinical evaluation of moxalactam.Randomized comparative study of moxalactam and cefazolin in the treatment of acute urinary tract infections in adults.

P2860

Q34707883-84B7B660-E7DF-4005-9124-3DF679A0E584 Q35674991-96C2EC2D-CC68-4F33-9249-5E9945E69A54 Q35675885-3E542311-6CA1-43D3-AC1E-FD9369402E4D Q35676060-F12D40E1-F100-4B47-8265-DAE597F5B53B Q35712352-C655242C-33FB-47DE-90A8-E24AC5F323DF Q35712560-8802BE14-EE24-4B36-824C-5F4F91B93C8D Q35754903-38AF3800-DD9B-4C28-8257-215B699D0899 Q35761938-2BF5AEF5-4F52-4E65-A1FA-99DA051419AC Q39857079-13E59B79-C7EB-491C-85A4-224017C48183 Q42248639-6BBEE1F1-6401-4579-A17D-494D852EB07C

P2860

Moxalactam therapy for a wide spectrum of bacterial infections in adults.

http://www.wikidata.org/entity/Q35669539

description

1981 nî lūn-bûn

@nan

1981年の論文

@ja

1981年論文

@yue

1981年論文

@zh-hant

1981年論文

@zh-hk

1981年論文

@zh-mo

1981年論文

@zh-tw

1981年论文

@wuu

1981年论文

@zh

1981年论文

@zh-cn

name

Moxalactam therapy for a wide spectrum of bacterial infections in adults.

@ast

Moxalactam therapy for a wide spectrum of bacterial infections in adults.

@en

type

label

Moxalactam therapy for a wide spectrum of bacterial infections in adults.

@ast

Moxalactam therapy for a wide spectrum of bacterial infections in adults.

@en

prefLabel

Moxalactam therapy for a wide spectrum of bacterial infections in adults.

@ast

Moxalactam therapy for a wide spectrum of bacterial infections in adults.

@en

P1433

Q35669539-8C4CCC6F-3275-41FD-A0F4-14BCD35E5F74

P1476

Q35669539-41F6FDAC-540B-4311-9DA4-7AEAA73609E2

P2093

Q35669539-7F9AC174-B80A-4B34-9A63-03AA8F8709C8

Q35669539-968FAE3A-5D7B-425E-AA13-ED76848A1B47

Q35669539-D6E434B5-2F0B-49AD-90B5-D1CC78EAF47B

Q35669539-EAC80791-9032-4CD0-AEB2-3A5FFE4F6668

P2860

Q35669539-33AFDFB6-1A50-41B4-AE80-4DC2177D2568

Q35669539-41EA6161-3E11-4923-8434-8BD0A8BB02FD

Q35669539-4AC8FA10-DCB9-4B99-B1A3-B5A390F64CCA

Q35669539-4F2E6930-235F-4788-88B0-1E2DDF308E32

Q35669539-7CAE034D-57F7-4196-B27F-4B9B216C0D88

Q35669539-844E744E-6F18-4C36-86E4-B52DA08620B7

Q35669539-A68D04A1-90C4-4DC6-A0AC-C6CDF8E504BD

Q35669539-AF504A66-3CA0-4D2B-9D8E-0C84CC2D3A63

Q35669539-C2920221-8BA0-42B1-84A9-8DB9FE7FF657

P304

Q35669539-CECFA180-0AE5-4BE1-A548-00044C5E7EB8

P31

Q35669539-54377627-D655-48F2-9DFA-D32994B17659

P356

Q35669539-2E7EE58E-52E5-474B-95D6-55F51E6FEECF

P407

Q35669539-B901172C-CE0D-4914-8B5B-41A1F26271FE

P433

Q35669539-51C47BFB-A6B6-4FB5-A54D-827B07AC3F52

P478

Q35669539-CB857A07-71CF-4137-9779-4D8EA4FA03F1

P577

Q35669539-43679FA5-7B66-4A02-A137-ACF784EA50D5

P698

Q35669539-FB51DCF8-881F-4482-B332-D68D25090C32

P932

Q35669539-CC1DECFB-DD30-4C8A-A4D6-9D7A8773F9DF

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Moxalactam therapy for a wide spectrum of bacterial infections in adults.

@en

P2093

Crossley KB

http://www.w3.org/2001/XMLSchema#string

Rotschafer J

http://www.w3.org/2001/XMLSchema#string

Solliday J

http://www.w3.org/2001/XMLSchema#string

Tofte RW

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers.

The fetid foot: lower-extremity infections in patients with diabetes mellitus.

Aerobic gram-negative bacillary pneumonias.

Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.

Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds.

LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activity.

Cefoxitin: an overview of clinical studies in the United States.

Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients.

In vitro activity of LY127935.

P304

740-744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.19.5.740

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

1981-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6457555

http://www.w3.org/2001/XMLSchema#string

P932

181515

http://www.w3.org/2001/XMLSchema#string